Association of financial toxicity (FT) with depression, anxiety, and quality of life (QoL) in older patients with advanced cancer: An analysis of 544 patients from 31 practices in the University of Rochester NCI Community Oncology Research Program (UR NCORP).

Authors

null

Asad Arastu

University of Rochester Medical Center, Rochester, NY, US

Asad Arastu , Joseph Ciminelli , Eva Culakova , Lianlian Lei , Huiwen Xu , David W. Dougherty , Mostafa R. Mohamed , Megan Wells , Paul Duberstein , Marie Anne Flannery , Gary R. Morrow , Charles Stewart Kamen , Chintan Pandya , Jeffrey L. Berenberg , Valerie Aarne , Supriya Gupta Mohile

Organizations

University of Rochester Medical Center, Rochester, NY, US, University of Rochester, Rochester, NY, University of Rochester Medical Center, Rochester, NY, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, Wilmot Cancer Institute/University of Rochester Medical Center, Rochester, NY, Tripler Army Medcl Ctr, Honolulu, HI

Research Funding

NIH

Background: Financial toxicity, or the strain caused by paying for health care services, can undermine the mental health and QoL of patients (pts) in cancer care. This study examined associations of FT with depression, anxiety, and QoL in older pts with advanced cancer. Methods: This is a secondary analysis of baseline data from a Geriatric Assessment intervention study conducted by UR NCORP (URCC 13070; PI: Mohile). At baseline, pts were categorized as experiencing FT if they reported any one of the following: delaying medications due to cost, insufficient income in a typical month for food and housing, or insufficient income in a typical month for other basic needs. This definition of FT is consistent with those used in previous research. Pts also completed the Geriatric Depression Scale (GDS, score 0-15), the Generalized Anxiety Disorder-7 (GAD7, score 0-21), and the Functional Assessment of Cancer Therapy- General (FACT-G) to assess overall QoL. Associations of FT with depression, anxiety, and QoL were assessed in separate multivariate linear regression models controlling for covariates at p < 0.1. Results: Among 544 pts (mean age 77; range 70-96; 49% female), 18% (98 pts) experienced FT. In multivariate regression analysis, FT was significantly associated with all 3 outcome measures. On average, pts experiencing FT scored 0.77 points higher (p = 0.02) on the GDS (indicating greater depression severity), 1.77 points higher (p < 0.01) on the GAD7 (indicating greater anxiety severity), and 5.2 points lower (p < 0.01) on the FACT-G (indicating lower QoL). Conclusions: Older pts with advanced cancer who experience income and cost-related barriers to quality cancer care reported worse depression, anxiety, and QoL than those without FT. Given the association between FT and these measures, these 3 FT questions may help with screening to identify vulnerable older pts who may have lower QoL and be at increased risk for depression and anxiety due to FT.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2018 ASCO Annual Meeting

Session Type

Publication Only

Session Title

Publication Only: Patient and Survivor Care

Track

Patient and Survivor Care

Sub Track

Geriatric Oncology

Citation

J Clin Oncol 36, 2018 (suppl; abstr e22037)

DOI

10.1200/JCO.2018.36.15_suppl.e22037

Abstract #

e22037

Abstract Disclosures

Similar Abstracts

First Author: Surbhi Singhal

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Second-line chemotherapy in elderly patients with advanced pancreatic cancer: A mono-institutional retrospective experience.

First Author: Giovanni Trovato

First Author: Takahito Awatsu